SEC Form 3 · accession 0001209191-15-056935
ADURO BIOTECH, INC. · ADRO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Stephen A Sherwin
Director
Period of report
Jun 25, 2015
Accepted (ET)
Jun 26, 2015 · 8:31 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001435049
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | holding | — | — | — | 36,300 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $1.00 | holding | — | — | — | — | Jul 30, 2024 | Common Stock | 14,400 | — | D |
| Stock Option (right to buy)F2 | $1.45 | holding | — | — | — | — | Jan 9, 2025 | Common Stock | 10,440 | — | D |
Explanation of responses
- F1The shares subject to the Option vest in 48 equal monthly installments from the vesting commencement date of July 31, 2014.
- F2The shares subject to the Option vest in 48 equal monthly installments from the vesting commencement date of January 10, 2015.